Skip to main content
Contact Us
Subscribe
E-Edition
69°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Jim Cramer says CEOs must properly explain the bad news in every quarter
October 30, 2024
Tags
Stock Picks
Markets
stocks
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
US: News
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
Tags
LILLY DRN
Starbucks Corp
Investment strategy
From
CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
October 30, 2024
Tags
Earnings
US: News
Pharmaceuticals
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
PRO: Playbooks
Meta Platforms Inc
Microsoft Corp
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
LILLY DRN
Investment strategy
Microsoft Corp
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Biotech and Pharmaceuticals
Alzheimer's disease
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
Tags
Investment strategy
Trump Media & Technology Group Corp
LILLY DRN
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Microsoft Corp
Health & Science
Health care industry
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
Tags
LILLY DRN
Markets
Investment strategy
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Biotech and Pharmaceuticals
LILLY DRN
Social issues
From
CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
October 15, 2024
Tags
Health care industry
Business
LILLY DRN
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
Pharmaceuticals
Novo Nordisk A/S
Europe: Top News And Analysis
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
PepsiCo Inc/
Ford Motor Co
Diamondback Energy Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
October 03, 2024
Tags
General Motors Co
Business News
Economy
From
CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
Tags
Business News
Science
Manufacturing
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.